Furqan Ilyas CanSino Biologics has entered into a partnership with AstraZeneca to offer “contract development and manufacturing services,” extending a helping hand to the Anglo-Swedish pharmaceutical giant’s messenger RNA (mRNA) vaccine initiative, as announced by the Chinese firm. Through a communication to the Shanghai stock exchange, CanSino unveiled its commitment to engage in the production … Continue reading Milestone Achieved: China’s Homegrown mRNA Vaccine Approval